{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:42:58Z","timestamp":1792510978566,"version":"4.5.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Stroke"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n            <jats:title>Background and purpose:<\/jats:title>\n            <jats:p>We performed a systemic review and meta-analysis to elucidate the effectiveness and safety of dual antiplatelet (DAPT) therapy with P2Y12 inhibitors (clopidogrel\/ticagrelor) and aspirin versus aspirin monotherapy in patients with mild ischemic stroke or high-risk transient ischemic attack.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>\n              Following Preferred Reported Items for Systematic Review and Meta-Analysis standards for meta-analyses, Medline, Embase, Cochrane Central Register of Controlled Trials, and the Cochrane Library were searched for randomized controlled trials that included patients with a diagnosis of an acute mild ischemic stroke or high-risk transient ischemic attack, intervention of DAPT therapy with clopidogrel\/ticagrelor and aspirin versus aspirin alone from January 2012 to July 2020. The outcomes included subsequent stroke, all-cause mortality, cardiovascular death, hemorrhage (mild, moderate, or severe), and myocardial infarction. A DerSimonian-Laird random-effects model was used to estimate pooled risk ratio (RR) and corresponding 95% CI in R package meta. We assessed the heterogeneity of data across studies with use of the Cochran Q statistic and\n              <jats:italic>I<\/jats:italic>\n              <jats:sup>2<\/jats:sup>\n              test.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>\n              Four eligible trials involving 21 493 participants were included in the meta-analysis. DAPT therapy started within 24 hours of symptom onset reduced the risk of stroke recurrence by 24% (RR, 0.76 [95% CI, 0.68\u20130.83],\n              <jats:italic>I<\/jats:italic>\n              <jats:sup>2<\/jats:sup>\n              =0%) but was not associated with a change in all-cause mortality (RR, 1.30 [95% CI, 0.90\u20131.89],\n              <jats:italic>I<\/jats:italic>\n              <jats:sup>2<\/jats:sup>\n              =0%), cardiovascular death (RR, 1.34 [95% CI, 0.56\u20133.17],\n              <jats:italic>I<\/jats:italic>\n              <jats:sup>2<\/jats:sup>\n              =0%), mild bleeding (RR, 1.25 [95% CI, 0.37\u20134.29],\n              <jats:italic>I<\/jats:italic>\n              <jats:sup>2<\/jats:sup>\n              =94%), or myocardial infarction (RR, 1.45 [95% CI, 0.62\u20133.39],\n              <jats:italic>I<\/jats:italic>\n              <jats:sup>2<\/jats:sup>\n              =0%). However, DAPT was associated with an increased risk of severe or moderate bleeding (RR, 2.17 [95% CI, 1.16\u20134.08],\n              <jats:italic>I<\/jats:italic>\n              <jats:sup>2<\/jats:sup>\n              =41%); further sensitivity tests found that the association was limited to trials with DAPT treatment duration over 21 days (RR, 2.86 [95% CI, 1.75\u20134.67],\n              <jats:italic>I<\/jats:italic>\n              <jats:sup>2<\/jats:sup>\n              =0%) or ticagrelor (RR, 2.17 [95% CI, 1.16\u20134.08],\n              <jats:italic>I<\/jats:italic>\n              <jats:sup>2<\/jats:sup>\n              =37%) but not within 21 days or clopidogrel.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>In patients with noncardioembolic mild stroke or high-risk transient ischemic attack, DAPT with aspirin and clopidogrel\/ticagrelor is more effective than aspirin alone for recurrent stroke prevention with a small absolute increase in the risk of severe or moderate bleeding.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/strokeaha.120.033040","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T09:11:33Z","timestamp":1622106693000},"page":"2250-2257","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":18,"title":["P2Y12 Inhibitors Plus Aspirin Versus Aspirin Alone in Patients With Minor Stroke or High-Risk Transient Ischemic Attack"],"prefix":"10.1161","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4713-5418","authenticated-orcid":true,"given":"Zi-Xiao","family":"Li","sequence":"first","affiliation":[{"name":"China National Clinical Research Center for Neurological Diseases (Z.-X.L., Y. Xiong, H.-Q.G., Y.-J.W.), Beijing Tiantan Hospital, Capital Medical University, China."},{"name":"Vascular Neurology, Department of Neurology (Z.-X.L., Y. Xiong, Y.-J.W.), Beijing Tiantan Hospital, Capital Medical University, China."},{"name":"Chinese Institute for Brain Research, Beijing, China (Z.-X.L., Y. Xiong)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1353-2295","authenticated-orcid":true,"given":"Yunyun","family":"Xiong","sequence":"additional","affiliation":[{"name":"China National Clinical Research Center for Neurological Diseases (Z.-X.L., Y. Xiong, H.-Q.G., Y.-J.W.), Beijing Tiantan Hospital, Capital Medical University, China."},{"name":"Vascular Neurology, Department of Neurology (Z.-X.L., Y. Xiong, Y.-J.W.), Beijing Tiantan Hospital, Capital Medical University, China."},{"name":"Chinese Institute for Brain Research, Beijing, China (Z.-X.L., Y. Xiong)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1608-1856","authenticated-orcid":true,"given":"Hong-Qiu","family":"Gu","sequence":"additional","affiliation":[{"name":"China National Clinical Research Center for Neurological Diseases (Z.-X.L., Y. Xiong, H.-Q.G., Y.-J.W.), Beijing Tiantan Hospital, Capital Medical University, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6116-475X","authenticated-orcid":true,"given":"Marc","family":"Fisher","sequence":"additional","affiliation":[{"name":"Stroke Division, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (M.F.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1237-1162","authenticated-orcid":true,"given":"Ying","family":"Xian","sequence":"additional","affiliation":[{"name":"Department of Neurology, Duke University Medical Center, Durham, NC (Y. Xian)."},{"name":"Duke Clinical Research Institute, Duke University, Durham, NC (Y. Xian)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2912-0714","authenticated-orcid":true,"given":"S. Claiborne","family":"Johnston","sequence":"additional","affiliation":[{"name":"Dell Medical School, University of Texas, Austin (S.C.J.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9976-2341","authenticated-orcid":true,"given":"Yong-Jun","family":"Wang","sequence":"additional","affiliation":[{"name":"China National Clinical Research Center for Neurological Diseases (Z.-X.L., Y. Xiong, H.-Q.G., Y.-J.W.), Beijing Tiantan Hospital, Capital Medical University, China."},{"name":"Vascular Neurology, Department of Neurology (Z.-X.L., Y. Xiong, Y.-J.W.), Beijing Tiantan Hospital, Capital Medical University, China."},{"name":"Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, China (Y.-J.W.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1159\/000341696"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.37991.635266.44"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.22.2901"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215340"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1800410"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000211"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.8662"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi754"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.07.058"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1916870"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70250-8"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/ijs.12129"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.2531"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.040713"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198806303182605"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811123392002"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.17.5.808"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042087"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13695"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k5108"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065754"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-016-8260-7"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/ijs.12050"}],"container-title":["Stroke"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/STROKEAHA.120.033040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T15:16:11Z","timestamp":1715613371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/STROKEAHA.120.033040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.1161\/STROKEAHA.120.033040"],"URL":"https:\/\/doi.org\/10.1161\/strokeaha.120.033040","relation":{},"ISSN":["0039-2499","1524-4628"],"issn-type":[{"value":"0039-2499","type":"print"},{"value":"1524-4628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"2020-10-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}